<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146479">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02140086</url>
  </required_header>
  <id_info>
    <org_study_id>RBT_03</org_study_id>
    <secondary_id>RBT_03</secondary_id>
    <nct_id>NCT02140086</nct_id>
  </id_info>
  <brief_title>Buteyko Based Remedial Breathing Therapy With Children With Asthma</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>ARCIM Institute Academic Research in Complementary and Integrative Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ARCIM Institute Academic Research in Complementary and Integrative Medicine</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized, controlled trial to investigate the effects of a buteyko based remedial
      breathing therapy on children with asthma regarding to their symptoms, use of medication and
      lung function tests.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Reduction of Betamimetics (-30%) at 3- and/or 6-month follow up</measure>
    <time_frame>asthmaspezific parameters are measured before and after intervention as well as 3- and 6- month follow up</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>ACQ</measure>
    <time_frame>parameters are measured before and after intervention as well as 3- and 6- month follow up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Scores of the ACQ (Asthma Control Questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PAQLQ</measure>
    <time_frame>parameters are measured before and after intervention as well as 3- and 6- month follow up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Scores of PAQLQ (Paediatric Asthma Quality of Life Questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AFB</measure>
    <time_frame>parameters are measured before and after intervention as well as 3- and 6- month follow up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Scores of the AFB (ARCIM Questionnaire) regarding to asthma symptoms of the last 3 month (AFB is not validated)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Flow</measure>
    <time_frame>parameters are measured before and after intervention as well as 3- and 6- month follow up</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NO-measurement nasal and oral</measure>
    <time_frame>parameters are measured before and after intervention as well as 3- and 6- month follow up</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Buteyko-Questionnaire</measure>
    <time_frame>parameters are measured before and after intervention as well as 3- and 6- month follow up</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>parameters of spirometry</measure>
    <time_frame>parameters are measured before and after intervention as well as 3- and 6- month follow up</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PACQLQ</measure>
    <time_frame>parameters are measured before and after intervention as well as 3- and 6- month follow up</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Buteyko based Remedial Breathing Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Buteyko based Remedial Breathing Therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waiting List</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Training in the course of the study</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Buteyko based Remedial Breathing Therapy</intervention_name>
    <description>Buteyko based remedial Breathing Therapy after Dr. Buteyko</description>
    <arm_group_label>Buteyko based Remedial Breathing Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  signed informed consent of the parents

          -  age 6- 15 years

          -  information and consent of the consulting doctor

          -  levels of asthma therapy 1-3

        Exclusion Criteria:

          -  participation in another study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Filderklinik</name>
      <address>
        <city>Filderstadt</city>
        <state>Baden-WÃ¼rttemberg</state>
        <zip>70794</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 15, 2014</lastchanged_date>
  <firstreceived_date>May 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>Buteyko</keyword>
  <keyword>remedial breathing</keyword>
  <keyword>children</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
